Innate Pharma S.A. (IPHA)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD

Add to watchlist

2.7900

-0.0800

(-2.79%)

At close: 04:00PM EDT

Loading interactive chart...

Business Wire
Innate Pharma Announces Its Participation in Upcoming Investor Conferences
MARSEILLE, France, May 28, 2024--Innate Pharma announces its participation in upcoming investor conferences
Business Wire
Innate Pharma Highlights Abstracts Selected for ASCO 2024 Annual Meeting
MARSEILLE, France, May 24, 2024--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") announced today that five abstracts with Innate’s drug candidates have been accepted for the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting, taking place May 31-June 4, 2024 in Chicago, Illinois.
Business Wire
Outcome of Innate Pharma’s 2024 Annual General Meeting
MARSEILLE, France, May 23, 2024--Outcome of Innate Pharma’s 2024 Annual General Meeting